Internal Medicine, Gastroenterology · New York, NY
NPI
1033389689
Since 2008
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
232 E 30th St
New York, NY, 10016
Phone (212) 889-5544
Groups this clinician bills Medicare through
Medicare paid, 2024
$8,121
95 services
Medicare patients, 2024
39
Average age 71
Drug cost, 2024
$849K
587 prescriptions
Company payments, 2025
$22K
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lauren K Schwartz was code 99214 (office e&m - established), 83 times for 38 patients. In total Lauren K Schwartz billed 95 services in 6 codes, and Medicare paid $8,121.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-05-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 83 | 38 | $84.80 | $7,038 |
By year: 2022 $24K for 187 services; 2023 $15K for 131 services; 2024 $8,121 for 95 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lauren K Schwartz prescribed most often to Medicare patients was Gentamicin Sulfate, with 51 prescriptions and refills. In total Lauren K Schwartz wrote 587 Medicare prescriptions that cost $849K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gentamicin Sulfate Generic | 51 | 51 | Under 11 | $293 |
| Famotidine Famotidine/Pf | 51 | 51 | Under 11 | $732 |
| Vancomycin Hcl Generic | 46 | 46 | Under 11 | $2,302 |
| Cefazolin Sodium Generic | 46 | 46 | Under 11 | $109 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 45 | 51 | Under 11 | $2,309 |
| Omeprazole Generic | 45 | 109 | 15 | $783 |
| Famotidine Generic | 35 | 91 | Under 11 | $559 |
| Pantoprazole Sodium Generic | 29 | 74 | Under 11 | $368 |
| Morphine Sulfate Generic | 29 | 29 | Under 11 | $453 |
| Creon Lipase/Protease/Amylase | 21 | 35 | Under 11 | $52K |
| Zenpep Lipase/Protease/Amylase | 18 | 18 | Under 11 | $30K |
| Gattex Teduglutide | 16 | 18 | Under 11 | $714K |
| Loperamide Loperamide Hcl | 13 | 13 | Under 11 | $490 |
| Mirtazapine Generic | 12 | 14 | Under 11 | $145 |
| Pentasa Mesalamine | 12 | 12 | Under 11 | $17K |
Brand drugs: 137 claims; generic drugs: 450 claims; opioid claims: 29.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lauren K Schwartz $22K ($22K in general payments such as food, travel and fees) from 13 companies. The largest payer was Takeda Pharmaceuticals U.S.A., Inc. with $20K.
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 11 | $20K |
| Janssen Biotech, Inc. JNJ | 31 | $665 |
| Abbvie Inc. ABBV | 33 | $634 |
| Pfizer Inc. PFE | 16 | $260 |
| Celltrion USA Inc. 068270.KS | 11 | $236 |
| QOL Medical, LLC | 4 | $162 |
| Ardelyx, Inc. ARDX | 4 | $107 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 3 | $53.52 |
| Madrigal Pharmaceuticals MDGL | 1 | $41.96 |
| Vibrant Gastro, Inc. | 1 | $24.7 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.